These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33629248)

  • 21. [(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and unknown origin primary tumor. Current usefulness and future perspectives].
    Duch J
    Med Clin (Barc); 2013 Jan; 140(1):22-3. PubMed ID: 23122613
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo
    Regelink JC; Zwezerijnen GJC; Groen RJW; Raijmakers PG; Zweegman S
    Br J Haematol; 2023 Mar; 200(6):755-758. PubMed ID: 36480438
    [No Abstract]   [Full Text] [Related]  

  • 23. 18F-FDG PET/CT imaging in tendon xanthomatosis.
    Kim DW; Kim CG; Park SA; Na YC
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1403-4. PubMed ID: 18491088
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Am J Otolaryngol; 2019; 40(2):297-305. PubMed ID: 30473166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of fluorodeoxyglucose-positron-emission tomography/computed tomography for evaluating tumor response to nonsurgical treatment.
    Ishihara K; Kobayashi Y; Iwano M; Shiiba M; Yoshihara H; Satoh H; Akiyama K; Kumita S
    J Nippon Med Sch; 2011; 78(5):272-3. PubMed ID: 22041872
    [No Abstract]   [Full Text] [Related]  

  • 26.
    Luna B; Rubí S; Tugores C; Sampol C; Orta N; Peña C
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):248-249. PubMed ID: 32265144
    [No Abstract]   [Full Text] [Related]  

  • 27. Findings in the Gerstmann-Sträussler-Scheinker syndrome in an 18F-FDG PET-CT study.
    Achury C; Camacho V; Fernández A; Gómez-Ansón B; Jaller R; Carrió I
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):352-3. PubMed ID: 23084018
    [No Abstract]   [Full Text] [Related]  

  • 28. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
    Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
    Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Practice guidelines for PDG-PET cancer screening].
    Japanese Society of Nuclear Medicine
    Kaku Igaku; 2004 Nov; 41(4):1-21. PubMed ID: 15690769
    [No Abstract]   [Full Text] [Related]  

  • 31. Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis?
    Brunken RC
    J Nucl Cardiol; 2022 Feb; 29(1):97-100. PubMed ID: 32676908
    [No Abstract]   [Full Text] [Related]  

  • 32. Metastatic small cell neuroendocrine carcinoma of the pyriform sinus evaluated by ¹⁸F-FDG PET/CT.
    Treglia G; Bongiovanni M; Paone G; Ruberto T; Parvex-Leoni S; Giovanella L
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):125-7. PubMed ID: 25018134
    [No Abstract]   [Full Text] [Related]  

  • 33. FDG-PET/CT for cancer management.
    Otsuka H; Morita N; Yamashita K; Nishitani H
    J Med Invest; 2007 Aug; 54(3-4):195-9. PubMed ID: 17878667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of patient effective dose in a PET/CT test.
    Paiva FG; do Carmo Santana P; Mourão AP
    Appl Radiat Isot; 2019 Mar; 145():137-141. PubMed ID: 30599383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma?
    Caldarella C; Isgrò MA; Treglia I; Treglia G
    Int J Hematol; 2012 Dec; 96(6):685-91. PubMed ID: 23135876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-Flurodeoxyglucose and 18F-Sodium Fluoride Positron Emission Tomography/Computed Tomography Imaging of Arterial and Cutaneous Alterations in Pseudoxanthoma Elasticum.
    Mention PJ; Lacoeuille F; Leftheriotis G; Martin L; Omarjee L
    Circ Cardiovasc Imaging; 2018 Jan; 11(1):e007060. PubMed ID: 29321214
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis.
    Annunziata S; Pizzuto DA; Caldarella C; Galiandro F; Sadeghi R; Treglia G
    World J Gastroenterol; 2015 Oct; 21(40):11481-8. PubMed ID: 26523112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fever of unknown origin (FUO) due to deep-venous thrombosis: diagnostic importance of FDG PET/CT.
    Gungor S; Koc K; Ones T; Inanir S; Erdil TY; Turoglu HT
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):73-4. PubMed ID: 25444394
    [No Abstract]   [Full Text] [Related]  

  • 39. Should FDG PET/CT be used for the initial staging of breast cancer?
    Groheux D; Hindié E; Rubello D; Espié M; Baillet G; Giacchetti S; Misset JL; Moretti JL
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1539-42. PubMed ID: 19449002
    [No Abstract]   [Full Text] [Related]  

  • 40. Positron Emission Tomography Fluorine-18-Labeled 2-Deoxy-2-Fluoro-d-Glucose Tells a Complicated Story in the Aortic Aneurysm Wall.
    Curci JA; Beckman JA
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.